Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coya Tapia

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|September 29, 2019
Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrenceSara Imboden, Coya Tapia, Nadja Scheiwiller, et al.
BMC Cancer|November 11, 2015
Androgen receptor status is highly conserved during tumor progression of breast cancerAndré Grogg, Mafalda Trippel, Katrin Pfaltz, et al.
Plos One|April 18, 2015
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 studyZsuzsanna Varga, Estelle Cassoly, Qiyu Li, et al.
Cancer Cytopathology|July 7, 2011
Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytologyCoya Tapia, Kathrina Glatz, Ellen C Obermann, et al.
Molecular and Cellular Endocrinology|July 30, 2016
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndromeNesa Marti, José A Galván, Amit V Pandey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutationsRonald Simon, Soti Panussis, Robert Maurer, et al.
BMC Women'S Health|October 4, 2011
Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biologyBodour Salhia, Coya Tapia, Elia A Ishak, et al.
Oncotarget|September 7, 2019
TAK228 enhances antitumor activity of eribulin in triple negative breast cancerNicci Owusu-Brackett, Kurt W Evans, Argun Akcakanat, et al.
International Journal of Oncology|November 18, 2004
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia, Peter Schraml, Ronald Simon, et al.
Plos One|October 12, 2012
Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancerSara A Byron, Elizabeth Min, Tanya S Thal, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Acta Obstetricia Et Gynecologica Scandinavica|September 29, 2019
Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrenceSara Imboden, Coya Tapia, Nadja Scheiwiller, et al.
BMC Cancer|November 11, 2015
Androgen receptor status is highly conserved during tumor progression of breast cancerAndré Grogg, Mafalda Trippel, Katrin Pfaltz, et al.
Plos One|April 18, 2015
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 studyZsuzsanna Varga, Estelle Cassoly, Qiyu Li, et al.
Cancer Cytopathology|July 7, 2011
Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytologyCoya Tapia, Kathrina Glatz, Ellen C Obermann, et al.
Molecular and Cellular Endocrinology|July 30, 2016
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndromeNesa Marti, José A Galván, Amit V Pandey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutationsRonald Simon, Soti Panussis, Robert Maurer, et al.
BMC Women'S Health|October 4, 2011
Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biologyBodour Salhia, Coya Tapia, Elia A Ishak, et al.
Oncotarget|September 7, 2019
TAK228 enhances antitumor activity of eribulin in triple negative breast cancerNicci Owusu-Brackett, Kurt W Evans, Argun Akcakanat, et al.
International Journal of Oncology|November 18, 2004
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia, Peter Schraml, Ronald Simon, et al.
Plos One|October 12, 2012
Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancerSara A Byron, Elizabeth Min, Tanya S Thal, et al.
Pageof 5